2021 Programme

2021 PROGRAMME

30 March 2021

Closed meeting working group

covid & Vaccines

21 April 2021

09:30-11:00

PUBLIC DEBATE: pandemics & Vaccines, hera incubator

Pierre Delsaux
Deputy Director General, DG SANTÉ, European Commission

Michel Goldman
ULB President, I3h Institue

Maria Carvalho
Member of the European Parliament

Luc Debruyne
Strategy Advisor to CEO, CEPI Former CEO, GSK Vaccines

Heike Galbraith
Global Director rare diseases and vaccines, Pfizer

Sam Proesmans
Advisor to the Belgian Prime Minister

Elena Bonfiglioli
Regional business leader health and life sciences EMEA, Microsoft

Mehreen Khan
Financial Times Brussels Correspondent

11 May 2021

Closed meeting working group

EUROPEAN HEALTH DATA SPACE

10 June 2021

Public debate: EUROPEAN HEALTH DATA SPACE

Petra de Sutter
Belgian Deputy PM & Minister of Civil Service, Public Enterprises, Telecommunications & Post

Elena Bonfiglioli
Regional business leader health and life sciences EMEA, Microsoft

Mario Campolargo
Director General, DIGIT, European Commission

Bert Verdonck
Program Manager Health Data Initiatives and Gaia-X, Philips

Menno Kok
Managing Director, EIT Health Belgium & The Netherlands

John Gordon
Sr. Director, Innovation Lab Lead, International Developed Markets (IDM), Pfizer Digital

Thomas Kostera
Senior Policy Analyst, Bertelsmann Stiftung

8 July 2021

PUBLIC debate: RARE DISEASES, ADVANCED THERAPIES – GENE THERAPY

Michel Goldman
ULB President, I3h Institue

Hildegard Büning
President European Society of Gene and Cell Therapy

Simone Boselli
Public Affairs Director, Eurordis

Kaja Kantorska
Policy Officer Pharmaceuticals, DG SANTE, European Commission

Dirk Vander Mijnsbrugge. Medical Affairs Lead, Rare Diseases, Pfizer

Irene Norstedt
Director People Directorate, DG RTD, European Commission

Brieuc Van Damme Director-General Healthcare, RIZIV-INAMI